Published in Cancer Weekly, November 5th, 2002
In the study, 199 women with early-stage breast cancer were treated per the guidelines of one of three protocols of tumor bed irradiation alone using either an interstitial low dose rate or high dose rate implant. One hundred and twenty patients were treated on an inpatient basis with a low dose rate implant, and the remaining were treated on an outpatient basis with a high dose rate implant. Every implant was designed to irradiate the lumpectomy cavity plus a 1-2 cm...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.